Pay in 4 interest-free payments of $6.62 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
mild injection-site reactions in roughly 8 to 12% of users Co-prescriptions / Often combined with TB-500 (thymosin beta-4 fragment) for synergistic tissue repair Monitoring / Track pain scores (0 to 10 NRS) and range of motion weekly
Most are small
The LEADER trial demonstrated reduced rates of major adverse cardiovascular events (MACE)
Knegtel et al
US$ 26.84
US$ 29.12
US$ 23.43
US$ 26.65
US$ 29.12
US$ 22.87
US$ 27.23
US$ 20.30
